tirzepatide side effects sex drive Clinical review of how glucagon-like peptide-1 agonist obesity medications decrease sexual desire, and a biopsychosocial model for why we don't 'see' it The Impact of Glucagon-like Peptide-1

While GLP-1 agonists mimic just one hormone, tirzepatides, such as Zepbound and Mounjaro, mimic twoGLP-1 and gastric inhibitory polypeptide (GIP)which can help overcome plateaus

The dose is usually started low and increased gradually over time to help the body adjust and reduce side effects

Cited Sources Peer-reviewed literature Independent published research indexed from PubMed and peer-reviewed journals not Eon Peptides claims

Our Enhance Medical Weight Management Program is overseen by experienced medical professionals ensuring the highest standards of safety and efficacy

This post walks through situations where GLP-1 medications may not be a good fit, or where careful medical and nutrition oversight is essential